Skip to content

Vera Bradley VRA Short-term contingent consideration

Short-term contingent consideration at other companies

AudioEye logo
AudioEyeAEYE
$225K
CorMedix logo
CorMedixCRMD
$3.18M
N-able logo
N-ableNABL
$10.25M-30.5%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$213M-24.5%
XOMA Corporation logo
XOMA CorporationXOMA
$0
CorMedix logo
CorMedixCRMD
$102.4M

Other financials

Income statement

See full
Revenue$55.7M+7.8%
Gross profit$28.8M+26.6%
Operating income-$4.6M+74.0%
Net income-$4.8M+85.6%
EPS (diluted)-$0.17+85.8%

Balance sheet

See full
Cash & equivalents$12.5M+10.9%
Total debt$1.1M-59.3%
Total equity$127.0M-13.0%
Total assets$219.2M-18.2%

Cash flow

See full
Operating cash flow-$5.3M+70.7%
CapEx$333.0K-82.2%
Free cash flow-$5.6M+71.8%

Valuation

See full
Market cap$110.62M+89.5%
Enterprise value$99.22M+99.2%
P/S0.4×+0.2×

Profitability

See full
Gross margin47.9%-0.9pp
Operating margin-7.8%-2.0pp
Net margin-7%-3.0pp
FCF margin-5.8%

Returns & leverage

See full
Return on equity-14.1%-5.7pp
Debt / equity0.0×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Vera Bradley in its filing.

Tagged under the XBRL concept vra:ContingentConsiderationCurrent.

The official record: Vera Bradley’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Bradley's short-term contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Bradley's short-term contingent consideration?
Vera Bradley (VRA) reported short-term contingent consideration of $1.84M in Q1 2026.
How has Vera Bradley's short-term contingent consideration changed year-over-year?
Vera Bradley's short-term contingent consideration increased by 33.6% year-over-year, from $1.37M to $1.84M.
What does short-term contingent consideration mean?
This represents the portion of purchase price consideration payable to sellers of acquired businesses that is expected to be settled within one year. It reflects obligations contingent upon the achievement of specific future performance milestones or financial targets by the acquired entity. Investors monitor this to assess near-term cash outflow requirements related to inorganic growth strategies.